首页 > 最新文献

Eurosurveillance最新文献

英文 中文
Modelling practices, data provisioning, sharing and dissemination needs for pandemic decision-making: a European survey-based modellers' perspective, 2020 to 2022. 大流行病决策的建模实践、数据提供、共享和传播需求:欧洲基于调查的建模者的观点,2020年至2022年。
IF 7.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-10-01 DOI: 10.2807/1560-7917.ES.2025.30.42.2500216
Esther van Kleef, Wim Van Bortel, Elena Arsevska, Luca Busani, Simon Dellicour, Laura Di Domenico, Marius Gilbert, Sabine L van Elsland, Moritz Ug Kraemer, Shengjie Lai, Philippe Lemey, Stefano Merler, Zoran Milosavljevic, Annapaola Rizzoli, Danijela Simic, Andrew J Tatem, Maguelonne Teisseire, William Wint, Vittoria Colizza, Chiara Poletto

BACKGROUNDAdvanced outbreak analytics were instrumental in informing governmental decision-making during the COVID-19 pandemic. However, systematic evaluations of how modelling practices, data use and science-policy interactions evolved during this and previous emergencies remain scarce.AIMThis study assessed the evolution of modelling practices, data usage, gaps, and engagement between modellers and decision-makers to inform future global epidemic intelligence.METHODSWe conducted a two-stage semiquantitative survey among modellers in a large European epidemic intelligence consortium. Responses were analysed descriptively across early, mid- and late-pandemic phases. We used policy citations in Overton to assess policy impact.RESULTSOur sample included 66 modelling contributions from 11 institutions in four European countries. COVID-19 modelling initially prioritised understanding epidemic dynamics; evaluating non-pharmaceutical interventions and vaccination impacts later became equally important. Traditional surveillance data (e.g. case line lists) were widely available in near-real time. Conversely, real-time non-traditional data (notably social contact and behavioural surveys) and serological data were frequently reported as lacking. Gaps included poor stratification and incomplete geographical coverage. Frequent bidirectional engagement with decision-makers shaped modelling scope and recommendations. However, fewer than half of the studies shared open-access code.CONCLUSIONSWe highlight the evolving use and needs of modelling during public health crises. Persistent gaps in the availability of non-traditional data underscore the need to rethink sustainable data collection and sharing practices, including from for-profit providers. Future preparedness should focus on strengthening collaborative platforms, research consortia and modelling networks to foster data and code sharing and effective collaboration between academia, decision-makers and data providers.

背景在2019冠状病毒病大流行期间,先进的疫情分析有助于为政府决策提供信息。然而,在这次和以前的紧急情况中,对建模实践、数据使用和科学-政策相互作用如何演变的系统评价仍然很少。本研究评估了建模实践的演变、数据使用、差距以及建模者和决策者之间的参与,以便为未来的全球流行病情报提供信息。方法我们在一个大型欧洲流行病情报联盟的建模人员中进行了两阶段的半定量调查。对大流行早期、中期和后期各阶段的反应进行了描述性分析。我们使用奥弗顿的政策引用来评估政策影响。结果我们的样本包括来自四个欧洲国家的11个机构的66个模型贡献。COVID-19模型最初优先考虑了解流行动态;评估非药物干预措施和疫苗接种的影响后来变得同样重要。传统的监测数据(例如病例线清单)可以近实时地广泛获得。相反,经常报告缺乏实时非传统数据(特别是社会接触和行为调查)和血清学数据。差距包括分层不良和地理覆盖不全。与决策者频繁的双向接触塑造了模型的范围和建议。然而,只有不到一半的研究共享了开放获取代码。结论:我们强调了在公共卫生危机期间不断发展的建模使用和需求。非传统数据的可得性持续存在差距,这突出表明需要重新考虑可持续的数据收集和共享做法,包括营利性提供商的做法。未来的准备工作应侧重于加强协作平台、研究联盟和建模网络,以促进学术界、决策者和数据提供者之间的数据和代码共享以及有效合作。
{"title":"Modelling practices, data provisioning, sharing and dissemination needs for pandemic decision-making: a European survey-based modellers' perspective, 2020 to 2022.","authors":"Esther van Kleef, Wim Van Bortel, Elena Arsevska, Luca Busani, Simon Dellicour, Laura Di Domenico, Marius Gilbert, Sabine L van Elsland, Moritz Ug Kraemer, Shengjie Lai, Philippe Lemey, Stefano Merler, Zoran Milosavljevic, Annapaola Rizzoli, Danijela Simic, Andrew J Tatem, Maguelonne Teisseire, William Wint, Vittoria Colizza, Chiara Poletto","doi":"10.2807/1560-7917.ES.2025.30.42.2500216","DOIUrl":"10.2807/1560-7917.ES.2025.30.42.2500216","url":null,"abstract":"<p><p>BACKGROUNDAdvanced outbreak analytics were instrumental in informing governmental decision-making during the COVID-19 pandemic. However, systematic evaluations of how modelling practices, data use and science-policy interactions evolved during this and previous emergencies remain scarce.AIMThis study assessed the evolution of modelling practices, data usage, gaps, and engagement between modellers and decision-makers to inform future global epidemic intelligence.METHODSWe conducted a two-stage semiquantitative survey among modellers in a large European epidemic intelligence consortium. Responses were analysed descriptively across early, mid- and late-pandemic phases. We used policy citations in Overton to assess policy impact.RESULTSOur sample included 66 modelling contributions from 11 institutions in four European countries. COVID-19 modelling initially prioritised understanding epidemic dynamics; evaluating non-pharmaceutical interventions and vaccination impacts later became equally important. Traditional surveillance data (e.g. case line lists) were widely available in near-real time. Conversely, real-time non-traditional data (notably social contact and behavioural surveys) and serological data were frequently reported as lacking. Gaps included poor stratification and incomplete geographical coverage. Frequent bidirectional engagement with decision-makers shaped modelling scope and recommendations. However, fewer than half of the studies shared open-access code.CONCLUSIONSWe highlight the evolving use and needs of modelling during public health crises. Persistent gaps in the availability of non-traditional data underscore the need to rethink sustainable data collection and sharing practices, including from for-profit providers. Future preparedness should focus on strengthening collaborative platforms, research consortia and modelling networks to foster data and code sharing and effective collaboration between academia, decision-makers and data providers.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 42","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12555114/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145354183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Brugian filariasis in a German tourist after short-term travel to Sri Lanka, 2025. 2025年,一名德国游客在斯里兰卡短期旅行后患急性布鲁治丝虫病。
IF 7.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-10-01 DOI: 10.2807/1560-7917.ES.2025.30.43.2500793
Günther Slesak, Birgit Muntau, Dennis Tappe

A German traveller developed leg oedema with adenolymphangitis after a 3-week trip to Sri Lanka. Laboratory tests showed slight eosinophilia, positive filarial serology and motile microfilariae in day and night-time blood samples. PCR revealed 99% homology for Brugia malayi. Lymphatic filariasis has been eliminated in Sri Lanka, but zoonotic B. malayi has re-emerged. Physicians need to be alert and consider filariasis as potential differential diagnosis. Surveillance and vector control efforts should be sustained to prevent resurgence in Sri Lanka.

一名德国旅行者在斯里兰卡旅行3周后出现腿部水肿和腺淋巴炎。实验室检查显示轻度嗜酸性粒细胞增多,丝虫病血清学阳性,白夜血样中有微丝虫病。PCR结果显示,该菌株同源性达99%。淋巴丝虫病在斯里兰卡已被消灭,但人畜共患病的马来芽胞杆菌再次出现。医生需要保持警惕,并考虑丝虫病作为潜在的鉴别诊断。应继续开展监测和病媒控制工作,以防止疫情在斯里兰卡卷土重来。
{"title":"Acute Brugian filariasis in a German tourist after short-term travel to Sri Lanka, 2025.","authors":"Günther Slesak, Birgit Muntau, Dennis Tappe","doi":"10.2807/1560-7917.ES.2025.30.43.2500793","DOIUrl":"10.2807/1560-7917.ES.2025.30.43.2500793","url":null,"abstract":"<p><p>A German traveller developed leg oedema with adenolymphangitis after a 3-week trip to Sri Lanka. Laboratory tests showed slight eosinophilia, positive filarial serology and motile microfilariae in day and night-time blood samples. PCR revealed 99% homology for <i>Brugia malayi</i>. Lymphatic filariasis has been eliminated in Sri Lanka, but zoonotic <i>B. malayi</i> has re-emerged. Physicians need to be alert and consider filariasis as potential differential diagnosis. Surveillance and vector control efforts should be sustained to prevent resurgence in Sri Lanka.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 43","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12579318/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145407874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measles vaccine virus mutation following vaccination in a healthy child resulting in a false negative vaccine specific PCR test: Ontario, Canada, 2025. 在健康儿童接种麻疹疫苗后导致疫苗特异性PCR检测假阴性的麻疹疫苗病毒突变:加拿大安大略省,2025年。
IF 7.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-10-01 DOI: 10.2807/1560-7917.ES.2025.30.43.2500774
Sarah E Wilson, Vanessa Zubach, Brendan Lew, Maan Hasso, Romy Olsha, Marina I Salvadori, Navya Manoj, Joanne Hiebert

We report a case of a mild, self-limited rash illness in a child 18 days after measles-mumps-rubella-varicella vaccination. Initial testing with a PCR-based method failed to detect vaccine virus. Sequencing later identified a novel mutation in the probe-binding site of the vaccine assay that had arisen after vaccination and resulted in the false-negative PCR test results.

我们报告一个病例轻度,自限性皮疹疾病在儿童18天后麻疹-腮腺炎-风疹-水痘疫苗。用基于聚合酶链反应的方法进行的初步测试未能检测到疫苗病毒。随后测序确定了疫苗试验探针结合位点的新突变,该突变在接种疫苗后出现,并导致PCR检测结果假阴性。
{"title":"Measles vaccine virus mutation following vaccination in a healthy child resulting in a false negative vaccine specific PCR test: Ontario, Canada, 2025.","authors":"Sarah E Wilson, Vanessa Zubach, Brendan Lew, Maan Hasso, Romy Olsha, Marina I Salvadori, Navya Manoj, Joanne Hiebert","doi":"10.2807/1560-7917.ES.2025.30.43.2500774","DOIUrl":"10.2807/1560-7917.ES.2025.30.43.2500774","url":null,"abstract":"<p><p>We report a case of a mild, self-limited rash illness in a child 18 days after measles-mumps-rubella-varicella vaccination. Initial testing with a PCR-based method failed to detect vaccine virus. Sequencing later identified a novel mutation in the probe-binding site of the vaccine assay that had arisen after vaccination and resulted in the false-negative PCR test results.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 43","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12579314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145408076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author's correction for Euro Surveill. 2025;30(19). 作者对欧洲监测的更正。2025;30(19)。
IF 7.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-10-01 DOI: 10.2807/1560-7917.ES.2025.30.43.251030c
{"title":"Author's correction for Euro Surveill. 2025;30(19).","authors":"","doi":"10.2807/1560-7917.ES.2025.30.43.251030c","DOIUrl":"10.2807/1560-7917.ES.2025.30.43.251030c","url":null,"abstract":"","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 43","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12579319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145408063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025. 2024年12月至2025年8月,意大利对口服策略有障碍的人群实施长效可注射卡波特韦的HIV暴露前预防(PrEP)的早期结果。
IF 7.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-10-01 DOI: 10.2807/1560-7917.ES.2025.30.39.2500739
Davide Moschese, Rozenn Esvan, Chiara Fusetti, Virginia Barchi, Maria Vittoria Cossu, Alessandro Giacinta, Samuel Lazzarin, Giulia Terracini, Francesco Caruso, Giulia Micheli, Donatella Maddalena, Giulia Del Duca, Francesco Petri, Gianluca Frate, Maddalena Matone, Damiano Farinacci, Andrea Giacomelli, Paolo Faccendini, Debora Visigalli, Sara Passacantilli, Agostino Riva, Andrea Antinori, Andrea Gori, Valentina Mazzotta

Between December 2024 and August 2025, two Italian HIV/STI clinics offered long-acting injectable cabotegravir (CAB-LA) for HIV prevention in 265 individuals, representing the first European real-world implementation. Participants were prioritised based on vulnerabilities compromising oral pre-exposure prophylaxis (PrEP), such as poor adherence, comorbidities and behavioural barriers. Adherence to injections exceeded 95%, tolerability was favourable and only 1.5% discontinued for drug-related reasons. These findings demonstrate the feasibility of CAB-LA in European clinical services and support its use in specific populations.

在2024年12月至2025年8月期间,意大利的两家艾滋病毒/性传播感染诊所为265人提供了长效注射卡波特韦(CAB-LA),这是欧洲首次在现实世界中实施。根据影响口服暴露前预防(PrEP)的脆弱性(如依从性差、合并症和行为障碍)对参与者进行优先排序。注射依从性超过95%,耐受性良好,只有1.5%因药物相关原因停药。这些发现证明了CAB-LA在欧洲临床服务中的可行性,并支持其在特定人群中的应用。
{"title":"Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025.","authors":"Davide Moschese, Rozenn Esvan, Chiara Fusetti, Virginia Barchi, Maria Vittoria Cossu, Alessandro Giacinta, Samuel Lazzarin, Giulia Terracini, Francesco Caruso, Giulia Micheli, Donatella Maddalena, Giulia Del Duca, Francesco Petri, Gianluca Frate, Maddalena Matone, Damiano Farinacci, Andrea Giacomelli, Paolo Faccendini, Debora Visigalli, Sara Passacantilli, Agostino Riva, Andrea Antinori, Andrea Gori, Valentina Mazzotta","doi":"10.2807/1560-7917.ES.2025.30.39.2500739","DOIUrl":"10.2807/1560-7917.ES.2025.30.39.2500739","url":null,"abstract":"<p><p>Between December 2024 and August 2025, two Italian HIV/STI clinics offered long-acting injectable cabotegravir (CAB-LA) for HIV prevention in 265 individuals, representing the first European real-world implementation. Participants were prioritised based on vulnerabilities compromising oral pre-exposure prophylaxis (PrEP), such as poor adherence, comorbidities and behavioural barriers. Adherence to injections exceeded 95%, tolerability was favourable and only 1.5% discontinued for drug-related reasons. These findings demonstrate the feasibility of CAB-LA in European clinical services and support its use in specific populations.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 39","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12495377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145211874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Open for application: Eurosurveillance is looking for a seconded national expert in 2026. 开放申请:Eurosurveillance将在2026年招聘一名国家专家。
IF 7.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-10-01 DOI: 10.2807/1560-7917.ES.2025.30.43.20251030
{"title":"Open for application: <i>Eurosurveillance</i> is looking for a seconded national expert in 2026.","authors":"","doi":"10.2807/1560-7917.ES.2025.30.43.20251030","DOIUrl":"10.2807/1560-7917.ES.2025.30.43.20251030","url":null,"abstract":"","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 43","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12579313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145408081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A local outbreak of iatrogenic botulism associated with cosmetic injections of botulinum neurotoxin-containing products, England, 2025. 当地爆发医源性肉毒杆菌中毒与美容注射含有肉毒杆菌神经毒素的产品,英国,2025。
IF 7.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-10-01 DOI: 10.2807/1560-7917.ES.2025.30.39.2500746
Joseph Jasperse, Kate Wilson, Sana Akbar, Iain Hayden, Qudsia Naseem, Alison Worthington, Amii Coglan, Matt Hewson, Alan Young, Min Fang, Yvonne Liu, Joanne Darke, Vanessa Wong, Gauri Godbole, Gareth J Hughes

In June 2025, 25 botulism cases were identified among recipients of botulinum neurotoxin-containing cosmetic injections in North East England. A case-control study indicated that cases were more likely to have attended two specific practitioners and received an unlicensed product (p < 0.001). Testing of seized product detected a potency (370 units/vial) that was higher than listed on its labelling (200 units/vial). Strengthened regulation of cosmetic procedures is necessary for mitigating public health risks, which are exacerbated by the availability of unlicensed products.

2025年6月,在英格兰东北部接受含肉毒杆菌神经毒素化妆品注射的患者中发现了25例肉毒杆菌中毒病例。一项病例对照研究表明,病例更有可能参加了两个特定的医生,并接受了未经许可的产品
{"title":"A local outbreak of iatrogenic botulism associated with cosmetic injections of botulinum neurotoxin-containing products, England, 2025.","authors":"Joseph Jasperse, Kate Wilson, Sana Akbar, Iain Hayden, Qudsia Naseem, Alison Worthington, Amii Coglan, Matt Hewson, Alan Young, Min Fang, Yvonne Liu, Joanne Darke, Vanessa Wong, Gauri Godbole, Gareth J Hughes","doi":"10.2807/1560-7917.ES.2025.30.39.2500746","DOIUrl":"10.2807/1560-7917.ES.2025.30.39.2500746","url":null,"abstract":"<p><p>In June 2025, 25 botulism cases were identified among recipients of botulinum neurotoxin-containing cosmetic injections in North East England. A case-control study indicated that cases were more likely to have attended two specific practitioners and received an unlicensed product (p < 0.001). Testing of seized product detected a potency (370 units/vial) that was higher than listed on its labelling (200 units/vial). Strengthened regulation of cosmetic procedures is necessary for mitigating public health risks, which are exacerbated by the availability of unlicensed products.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 39","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12495379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145211956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracking epidemiological shifts in hepatitis A in Portugal: a comparison of seroprevalence between two nationwide surveys, 2001 to 2002 and 2015 to 2016. 跟踪葡萄牙甲型肝炎的流行病学变化:2001年至2002年和2015年至2016年两次全国调查的血清患病率比较
IF 7.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-09-01 DOI: 10.2807/1560-7917.ES.2025.30.37.2500020
Vera Manageiro, Rita Matos, Paula Palminha, Helena Cortes-Martins, Baltazar Nunes, Rita de Sousa

Background: Hepatitis A incidence in Portugal declined from 20.1 to 0.4/100,000 population between 1987 and 2023, changing non-vaccinated population susceptibility. This shift has contributed to more frequent outbreaks, including in 2024-25, highlighting the need to enhance surveillance and integrate serological data.

Aim: We aimed to describe the exposure profile of the Portuguese population to hepatitis A virus (HAV) over time by estimating and comparing the seroprevalence of hepatitis A in two nationwide surveys.

Methods: Data from two cross-sectional seroprevalence studies performed in 2001-02 and 2015-16 in the population aged ≥ 2 years were analysed. Seroprevalence was weighted for population distribution by age, sex and region, and then analysed by birth cohort (1911 -2014) and compared using Poisson regression.

Results: Overall prevalence of anti-HAV IgG antibodies was 67.3% (95% CI: 64.2-70.3) in 2001-02 (n = 1,642) and 56.3% (95% CI: 52.4-60.2) in 2015-16 (n = 2,052), showing an 11-percentage-point decline. Birth cohort analysis revealed consistent seroprevalence within each cohort in both surveys, i.e. seroprevalence for the 1981-90 birth cohort was 16.7% and 18.7%, respectively, suggesting that higher seroprevalence is more closely associated with birth cohort (cohort effect) rather than a specific time point. Additionally, we found that individuals aged ≥ 30 years, born before the 1980s, and those with lower education had higher seroprevalence.

Conclusions: The immunological profile of anti-HAV antibodies in the Portuguese population has shifted over the last decades. High susceptibility and shifting age distribution of Hepatitis A-seropositive individuals highlight the need to revise future vaccination strategies in Portugal.

背景:1987年至2023年间,葡萄牙甲型肝炎发病率从20.1 /10万下降到0.4/10万,改变了未接种疫苗人群的易感性。这一转变导致疫情更加频繁,包括在2024-25年,突出了加强监测和整合血清学数据的必要性。目的:我们旨在通过估计和比较两项全国性调查中甲型肝炎的血清患病率来描述葡萄牙人口对甲型肝炎病毒(HAV)的暴露情况。方法:分析2001-02年和2015-16年在2岁以上人群中进行的两项横断面血清阳性率研究的数据。根据年龄、性别和地区对人口分布进行血清患病率加权,然后通过出生队列(1911 -2014)进行分析,并使用泊松回归进行比较。结果:2001-02年抗hav IgG抗体总患病率为67.3%(95% CI: 64.2-70.3)(n = 1642), 2015-16年为56.3%(95% CI: 52.4-60.2)(n = 2052),下降了11个百分点。出生队列分析显示,在两次调查中,每个队列的血清阳性率一致,即1981- 1990年出生队列的血清阳性率分别为16.7%和18.7%,这表明较高的血清阳性率与出生队列(队列效应)而不是特定的时间点更为密切相关。此外,我们发现年龄≥30岁、80年代以前出生和受教育程度较低的个体血清阳性率较高。结论:在过去的几十年里,葡萄牙人群中抗甲型肝炎抗体的免疫学特征发生了变化。甲型肝炎血清阳性个体的高易感性和年龄分布的变化突出了葡萄牙修订未来疫苗接种策略的必要性。
{"title":"Tracking epidemiological shifts in hepatitis A in Portugal: a comparison of seroprevalence between two nationwide surveys, 2001 to 2002 and 2015 to 2016.","authors":"Vera Manageiro, Rita Matos, Paula Palminha, Helena Cortes-Martins, Baltazar Nunes, Rita de Sousa","doi":"10.2807/1560-7917.ES.2025.30.37.2500020","DOIUrl":"10.2807/1560-7917.ES.2025.30.37.2500020","url":null,"abstract":"<p><strong>Background: </strong>Hepatitis A incidence in Portugal declined from 20.1 to 0.4/100,000 population between 1987 and 2023, changing non-vaccinated population susceptibility. This shift has contributed to more frequent outbreaks, including in 2024-25, highlighting the need to enhance surveillance and integrate serological data.</p><p><strong>Aim: </strong>We aimed to describe the exposure profile of the Portuguese population to hepatitis A virus (HAV) over time by estimating and comparing the seroprevalence of hepatitis A in two nationwide surveys.</p><p><strong>Methods: </strong>Data from two cross-sectional seroprevalence studies performed in 2001-02 and 2015-16 in the population aged ≥ 2 years were analysed. Seroprevalence was weighted for population distribution by age, sex and region, and then analysed by birth cohort (1911 -2014) and compared using Poisson regression.</p><p><strong>Results: </strong>Overall prevalence of anti-HAV IgG antibodies was 67.3% (95% CI: 64.2-70.3) in 2001-02 (n = 1,642) and 56.3% (95% CI: 52.4-60.2) in 2015-16 (n = 2,052), showing an 11-percentage-point decline. Birth cohort analysis revealed consistent seroprevalence within each cohort in both surveys, i.e. seroprevalence for the 1981-90 birth cohort was 16.7% and 18.7%, respectively, suggesting that higher seroprevalence is more closely associated with birth cohort (cohort effect) rather than a specific time point. Additionally, we found that individuals aged ≥ 30 years, born before the 1980s, and those with lower education had higher seroprevalence.</p><p><strong>Conclusions: </strong>The immunological profile of anti-HAV antibodies in the Portuguese population has shifted over the last decades. High susceptibility and shifting age distribution of Hepatitis A-seropositive individuals highlight the need to revise future vaccination strategies in Portugal.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 37","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12449678/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145085527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contribution of the EuroRotaNet surveillance network to rotavirus strain surveillance in Europe. 欧洲轮状病毒网监测网络对欧洲轮状病毒毒株监测的贡献。
IF 7.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-09-01 DOI: 10.2807/1560-7917.ES.2025.30.38.2400798
Natasha Marcella Vaselli, Miren Iturriza-Gómara, Daniel Hungerford

Two rotavirus strain surveillance networks operate in Europe: the World Health Organization Global Rotavirus Surveillance Network and the European Rotavirus Network (EuroRotaNet). We describe and appraise rotavirus strain surveillance, with a focus on EuroRotaNet, which has conducted rotavirus strain surveillance since 2007 across 21 European countries. Since EuroRotaNet began, epidemiological and genotype data has been collected on over 90,000 rotavirus-positive specimens. We identified distinct differences in strain distribution across seasons, countries, regions and age cohorts. As infant rotavirus vaccination has been rolled out in some European countries, the EuroRotaNet surveillance network is able to monitor changes in strain type circulation and signs of potential emergence of vaccine escape strains, comparing countries with and without vaccination programs. Despite natural fluctuations in strain distribution, the data show an increase in strain diversity after vaccine introduction, although no strain displacement due to vaccination nor emergence of unusual strains of epidemiologically significance were noted. The EuroRotaNet surveillance network takes a pragmatic approach to surveillance and is not overly prescriptive, creating a wide, engaged and sustainable network.

欧洲有两个轮状病毒毒株监测网络:世界卫生组织全球轮状病毒监测网络和欧洲轮状病毒网络(EuroRotaNet)。我们描述和评估轮状病毒毒株监测,重点是euroorotanet,自2007年以来在21个欧洲国家开展了轮状病毒毒株监测。自eurootanet启动以来,已收集了9万多个轮状病毒阳性标本的流行病学和基因型数据。我们发现菌株分布在季节、国家、地区和年龄组之间存在明显差异。随着婴儿轮状病毒疫苗接种已在一些欧洲国家推广,eurootanet监测网络能够监测毒株类型循环的变化和疫苗逃逸毒株可能出现的迹象,并对有和没有疫苗接种规划的国家进行比较。尽管菌株分布存在自然波动,但数据显示,在引入疫苗后,菌株多样性有所增加,尽管未注意到因接种疫苗而导致的菌株移位,也未注意到出现具有流行病学意义的异常菌株。eurootanet监控网络采用务实的方法进行监控,而不是过度规范,创建了一个广泛,参与和可持续的网络。
{"title":"Contribution of the EuroRotaNet surveillance network to rotavirus strain surveillance in Europe.","authors":"Natasha Marcella Vaselli, Miren Iturriza-Gómara, Daniel Hungerford","doi":"10.2807/1560-7917.ES.2025.30.38.2400798","DOIUrl":"10.2807/1560-7917.ES.2025.30.38.2400798","url":null,"abstract":"<p><p>Two rotavirus strain surveillance networks operate in Europe: the World Health Organization Global Rotavirus Surveillance Network and the European Rotavirus Network (EuroRotaNet). We describe and appraise rotavirus strain surveillance, with a focus on EuroRotaNet, which has conducted rotavirus strain surveillance since 2007 across 21 European countries. Since EuroRotaNet began, epidemiological and genotype data has been collected on over 90,000 rotavirus-positive specimens. We identified distinct differences in strain distribution across seasons, countries, regions and age cohorts. As infant rotavirus vaccination has been rolled out in some European countries, the EuroRotaNet surveillance network is able to monitor changes in strain type circulation and signs of potential emergence of vaccine escape strains, comparing countries with and without vaccination programs. Despite natural fluctuations in strain distribution, the data show an increase in strain diversity after vaccine introduction, although no strain displacement due to vaccination nor emergence of unusual strains of epidemiologically significance were noted. The EuroRotaNet surveillance network takes a pragmatic approach to surveillance and is not overly prescriptive, creating a wide, engaged and sustainable network.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 38","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12475894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145148356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection and characterisation of Xpert CT/NG assay Neisseria gonorrhoeae diagnostic escape mutants, England, June 2025. 专家CT/NG检测淋病奈瑟菌诊断逃逸突变体的检测和表征,英国,2025年6月。
IF 7.8 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2025-09-01 DOI: 10.2807/1560-7917.ES.2025.30.36.2500673
Melissa Jansen van Rensburg, Rachel Pitt-Kendall, Michelle Hincke, Penelope R Cliff, Jonathan Shaw, Katy Sinka, John Saunders, Helen Fifer, Sarah Alexander

We report the timely detection of a strain of Neisseria gonorrhoeae which was confirmed as a diagnostic escape mutant on the Cepheid Xpert CT/NG assay in England in June 2025. The reason for assay failure was a likely recombination event with Neisseria meningitidis, which removed both assay target sites. Seven historical putative Xpert CT/NG assay diagnostic escape mutants were also identified following subsequent in silico screening of gonococcal genome collections, but currently there is no evidence of widespread circulation.

我们报告在2025年6月在英国的造父变星Xpert CT/NG检测中及时检测到一株淋病奈瑟菌,该菌株被确认为诊断性逃逸突变体。试验失败的原因可能是与脑膜炎奈瑟菌的重组事件,它移除了两个试验靶点。在随后的淋球菌基因组收集的计算机筛选之后,还发现了7个历史上假定的Xpert CT/NG检测诊断逃逸突变体,但目前没有证据表明其广泛传播。
{"title":"Detection and characterisation of Xpert CT/NG assay <i>Neisseria gonorrhoeae</i> diagnostic escape mutants, England, June 2025.","authors":"Melissa Jansen van Rensburg, Rachel Pitt-Kendall, Michelle Hincke, Penelope R Cliff, Jonathan Shaw, Katy Sinka, John Saunders, Helen Fifer, Sarah Alexander","doi":"10.2807/1560-7917.ES.2025.30.36.2500673","DOIUrl":"10.2807/1560-7917.ES.2025.30.36.2500673","url":null,"abstract":"<p><p>We report the timely detection of a strain of <i>Neisseria gonorrhoeae</i> which was confirmed as a diagnostic escape mutant on the Cepheid Xpert CT/NG assay in England in June 2025. The reason for assay failure was a likely recombination event with <i>Neisseria meningitidis</i>, which removed both assay target sites. Seven historical putative Xpert CT/NG assay diagnostic escape mutants were also identified following subsequent in silico screening of gonococcal genome collections, but currently there is no evidence of widespread circulation.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"30 36","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432493/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145039475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Eurosurveillance
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1